EBAG9 and cancer: As a result, we identified eight common mutated genes (EBAG9, MTDH, ATP6V1C1, OPA1, ATCL6A, BCL6, SENP5, KRAS) in the three different cancer types and used them as cross-cancer biomarkers to perform an integrative network analysis.